Molecular Therapies in Thyroid CancerReportar como inadecuado




Molecular Therapies in Thyroid Cancer - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Northwestern University, Feinberg School of Medicine, Division of Hematology- Oncology, Department of Medicine, 676 North St. Clair Street, Suite 850, Chicago, IL 60611, USA





*

Author to whom correspondence should be addressed.



Abstract Thyroid cancer is a common diagnosis with greater than 34,000 cases per year in the United States. Early stage thyroid cancer is often managed with surgical intervention and radioactive iodine; however, for recurrent or metastatic disease, the treatment options, historically, have been limited to chemotherapy. Chemotherapy for metastatic thyroid cancer has been of limited efficacy. Encouragingly, molecular therapeutics have played a greater role in managing patients with advanced disease. These agents work primarily through disruption of tyrosine kinase pathways. This review will discuss the expanding role of molecular targets in managing patients with advanced thyroid cancer. View Full-Text

Keywords: advanced thyroid cancer; molecular therapy; tyrosine kinase inhibitors advanced thyroid cancer; molecular therapy; tyrosine kinase inhibitors





Autor: Timothy Huyck and Mark Agulnik *

Fuente: http://mdpi.com/



DESCARGAR PDF




Documentos relacionados